Eli Lilly and Company (LLY)

NYQ – Real vaqt narxi. Valyuta: USD

878.24

-18.76 (-2.09%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

874.72

-3.52 (-0.40%)

Bozordan keyin: Mar 27, 2026, 7:59 PM EDT

Kompaniya haqida

Eli Lilly and Company Qo'shma Shtatlar, Evropa, Xitoy, Yaponiya va xalqaro miqyosda inson farmatsevtika mahsulotlarini kashf qiladi, ishlab chiqadi, ishlab chiqaradi va sotadi. Kompaniya diabet uchun Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 kabi kardiyometabolik sog'liq mahsulotlarini taklif etadi; 2-toifa diabet uchun Jardiance, Mounjaro va Trulicity; va semirish uchun Zepbound. Shuningdek, u oshqozon saratoni yoki oshqozon-qizilo'ngach birlashmasi adenokarsinomasini ikkinchi bosqichda davolash uchun Cyramza; kolorektal saraton va bosh va bo'yin saratonlari uchun Erbitux; ko'krak bezi saratoni uchun Inluriyo; surunkali limfotsitar leykemiya yoki kichik limfotsitar limfoma uchun Jaypirca; metastatik NSCLCni davolash uchun Retevmo; klassik Xodjkin limfomasi uchun TYVYT; va ko'krak bezi saratoni uchun Verzenio kabi onkologiya mahsulotlarini taqdim etadi. Bundan tashqari, kompaniya immunitet mahsulotlarini taklif etadi, jumladan, og'ir atopik dermatit uchun Ebglyss; revmatoid artrit, atopik dermatit, og'ir soch to'kilishi va COVID-19 uchun Olumiant; yarali kolit uchun Omvoh; va blyashka psoriaz, psoriatik artrit, ankilozlovchi spondilit va rentgenologik bo'lmagan o'q spondiloartrit uchun Taltz. Shuningdek, u migrenni oldini olish va paroksizmal klaster bosh og'rig'i uchun Emgality, shuningdek, simptomatik Altsgeymer kasalligi uchun Kisubla taqdim etadi. Kompaniya Jardiance mahsulot oilasi uchun Boehringer Ingelheim Pharmaceuticals, Inc. bilan; va lebrikizumab uchun F. Hoffmann-La Roche Ltd va Genentech, Inc. bilan hamkorlikni yo'lga qo'ygan, shuningdek, Ebglyss uchun Almirall, S.A. bilan; va orforglipron uchun Chugai Pharmaceutical Co., Ltd bilan litsenzion kelishuvlarga ega. Eli Lilly and Company 1876 yilda tashkil etilgan va shtab-kvartirasi Indiana shtatining Indianapolis shahrida joylashgan.

Asosiy rahbarlar

Ism	Lavozim
Dr. Daniel M. Skovronsky M.D., Ph.D.	Chief Scientific & Product Officer and President of Lilly Research Laboratories
Dr. Ruth Gimeno Ph.D.	Group Vice President, Diabetes, Obesity & Cardiometabolic Research and Early Clinical Development
Kim Macko	Senior Director of R&D Strategy and Transformation
Mr. David A. Ricks	Chairman & CEO
Mr. Jacob S. Van Naarden	Executive VP & President of Lilly Oncology
Mr. Kevin Hern	Vice President of Investor Relations
Mr. Lucas E. Montarce	Executive VP & CFO